1-12 of 12
Authors: Kate Pinner
Sort by
Journal Article
0360 Shifts in Daytime Functioning Items on the Insomnia Severity Scale with Lemborexant after 6 Months of Treatment Free
Craig Chepke and others
Sleep, Volume 46, Issue Supplement_1, May 2023, Pages A159–A160, https://doi.org/10.1093/sleep/zsad077.0360
Published: 29 May 2023
Journal Article
0449 Correlations Between Sleep Parameters and ISI Total Score in Subjects with Moderate to Severe Insomnia Treated with Lemborexant Free
Margaret Moline and others
Sleep, Volume 45, Issue Supplement_1, June 2022, Page A199, https://doi.org/10.1093/sleep/zsac079.446
Published: 25 May 2022
Journal Article
0440 Subjective Sleep Outcomes with Lemborexant Among Subjects with Insomnia and Clinically Meaningful Decreases on the Insomnia Severity Index Free
Thomas Roth and others
Sleep, Volume 45, Issue Supplement_1, June 2022, Pages A195–A196, https://doi.org/10.1093/sleep/zsac079.437
Published: 25 May 2022
Journal Article
339 Long-term Perception of Medication Effectiveness in Subjects Receiving Lemborexant for up to 12 Months Free
Christopher Drake and others
Sleep, Volume 44, Issue Supplement_2, May 2021, Pages A135–A136, https://doi.org/10.1093/sleep/zsab072.338
Published: 03 May 2021
Journal Article
Long-term efficacy and tolerability of lemborexant compared with placebo in adults with insomnia disorder: results from the phase 3 randomized clinical trial SUNRISE 2 Open Access
Mikko Kärppä and others
Sleep, Volume 43, Issue 9, September 2020, zsaa123, https://doi.org/10.1093/sleep/zsaa123
Published: 26 June 2020
Journal Article
Erratum to: On-the-road driving performance the morning after bedtime administration of lemborexant in healthy adult and elderly volunteers Open Access
Annemiek Vermeeren and others
Sleep, Volume 43, Issue 7, July 2020, zsaa068, https://doi.org/10.1093/sleep/zsaa068
Published: 12 May 2020
Journal Article
0368 Efficacy and Tolerability of Lemborexant in Female and Male Subjects with Insomnia
Get access
Margaret Moline and others
Sleep, Volume 42, Issue Supplement_1, April 2019, Page A150, https://doi.org/10.1093/sleep/zsz067.367
Published: 12 April 2019
Journal Article
0369 Effect of Lemborexant on Sleep Architecture in Older Adults with Insomnia Disorder
Get access
Margaret Moline and others
Sleep, Volume 42, Issue Supplement_1, April 2019, Page A150, https://doi.org/10.1093/sleep/zsz067.368
Published: 12 April 2019
Journal Article
0367 Lemborexant Treatment for Insomnia: 6-month Safety
Get access
Mikko Kärppä and others
Sleep, Volume 42, Issue Supplement_1, April 2019, Pages A149–A150, https://doi.org/10.1093/sleep/zsz067.366
Published: 12 April 2019
Journal Article
0371 Lemborexant Treatment for Insomnia in Phase 3: Impact on Disease Severity
Get access
Tom Roth and others
Sleep, Volume 42, Issue Supplement_1, April 2019, Page A151, https://doi.org/10.1093/sleep/zsz067.370
Published: 12 April 2019
Journal Article
0370 Patient-reported Sleep Onset and Sleep Maintenance: Pooled Analyses of Lemborexant Phase 3 Studies
Get access
Phyllis C Zee and others
Sleep, Volume 42, Issue Supplement_1, April 2019, Pages A150–A151, https://doi.org/10.1093/sleep/zsz067.369
Published: 12 April 2019
Journal Article
On-the-road driving performance the morning after bedtime administration of lemborexant in healthy adult and elderly volunteers Open Access
Annemiek Vermeeren and others
Sleep, Volume 42, Issue 4, April 2019, zsy260, https://doi.org/10.1093/sleep/zsy260
Published: 31 December 2018
Advertisement
Advertisement